Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Influence of a nonfragile FHIT transgene on murine tumor susceptibility.

McCorkell KA, Mancini R, Siprashvili Z, Barnoski BL, Iliopoulos D, Siracusa LD, Zanesi N, Croce CM, Fong LY, Druck T, Huebner K.

Cytogenet Genome Res. 2007;118(2-4):196-203.

PMID:
18000371
[PubMed - indexed for MEDLINE]
2.

Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.

Cantor JP, Iliopoulos D, Rao AS, Druck T, Semba S, Han SY, McCorkell KA, Lakshman TV, Collins JE, Wachsberger P, Friedberg JS, Huebner K.

Int J Cancer. 2007 Jan 1;120(1):24-31.

PMID:
17019711
[PubMed - indexed for MEDLINE]
3.

Hypermethylation patterns in the Fhit regulatory region are tissue specific.

Guler G, Iliopoulos D, Han SY, Fong LY, Lubet RA, Grubbs CJ, Huebner K.

Mol Carcinog. 2005 Jul;43(3):175-81.

PMID:
15937960
[PubMed - indexed for MEDLINE]
4.

Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.

Kholodnyuk ID, Szeles A, Yang Y, Klein G, Imreh S.

Cancer Res. 2000 Dec 15;60(24):7119-25.

PMID:
11156420
[PubMed - indexed for MEDLINE]
Free Article
5.

The tumor spectrum in FHIT-deficient mice.

Zanesi N, Fidanza V, Fong LY, Mancini R, Druck T, Valtieri M, RĂ¼diger T, McCue PA, Croce CM, Huebner K.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10250-5. Epub 2001 Aug 21.

PMID:
11517343
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.

Cecener G, Tunca B, Egeli U, Bekar A, Tezcan G, Erturk E, Bayram N, Tolunay S.

Cell Mol Neurobiol. 2012 Mar;32(2):237-44. doi: 10.1007/s10571-011-9753-7. Epub 2011 Sep 18.

PMID:
21928112
[PubMed - indexed for MEDLINE]
7.

Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.

Siraj AK, Ibrahim M, Al-Rasheed M, Bu R, Bavi P, Jehan Z, Abubaker J, Murad W, Al-Dayel F, Ezzat A, El-Solh H, Uddin S, Al-Kuraya K.

Ann Hematol. 2007 Dec;86(12):887-95. Epub 2007 Aug 22.

PMID:
17712558
[PubMed - indexed for MEDLINE]
8.

Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.

Lea JS, Ashfaq R, Muneer S, Burbee DG, Miller DS, Minna JD, Muller CY.

J Soc Gynecol Investig. 2004 Jul;11(5):329-37.

PMID:
15219888
[PubMed - indexed for MEDLINE]
9.

Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.

Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M, Croce CM.

Cancer Res. 2003 Jul 1;63(13):3724-8.

PMID:
12839965
[PubMed - indexed for MEDLINE]
Free Article
10.

Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.

Foja S, Goldberg M, Schagdarsurengin U, Dammann R, Tannapfel A, Ballhausen WG.

Liver Int. 2005 Dec;25(6):1202-8.

PMID:
16343073
[PubMed - indexed for MEDLINE]
11.

Alterations of FHIT gene and P16 gene in nickel transformed human bronchial epithelial cells.

Ji WD, Chen JK, Lu JC, Wu ZL, Yi F, Feng SM.

Biomed Environ Sci. 2006 Aug;19(4):277-84.

PMID:
17044645
[PubMed - indexed for MEDLINE]
12.

Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.

Iliopoulos D, Guler G, Han SY, Johnston D, Druck T, McCorkell KA, Palazzo J, McCue PA, Baffa R, Huebner K.

Oncogene. 2005 Feb 24;24(9):1625-33.

PMID:
15674328
[PubMed - indexed for MEDLINE]
13.

Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.

Chang Q, Pang JC, Li KK, Poon WS, Zhou L, Ng HK.

Hum Pathol. 2005 Dec;36(12):1265-72.

PMID:
16311119
[PubMed - indexed for MEDLINE]
14.

Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis.

Wu Y, Meng L, Wang H, Xu Q, Wang S, Wu S, Xi L, Zhao Y, Zhou J, Xu G, Lu Y, Ma D.

Oncol Rep. 2006 Sep;16(3):625-9.

PMID:
16865265
[PubMed - indexed for MEDLINE]
15.

Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.

Zanesi N, Mancini R, Sevignani C, Vecchione A, Kaou M, Valtieri M, Calin GA, Pekarsky Y, Gnarra JR, Croce CM, Huebner K.

Cancer Res. 2005 Aug 1;65(15):6576-82.

PMID:
16061637
[PubMed - indexed for MEDLINE]
Free Article
16.

Effect of fragile histidine triad gene transduction on proliferation and apoptosis of human hepatocellular carcinoma cells.

Xu RH, Zheng LY, He DL, Tong J, Zheng LP, Zheng WP, Meng J, Xia LP, Wang CJ, Yi JL.

World J Gastroenterol. 2008 Jun 21;14(23):3754-8.

PMID:
18595145
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Influence of DNA methyltransferase 3b on FHIT expression and DNA methylation of the FHIT promoter region in hepatoma SMMC-7721 cells.

Wang JX, Zhang YG, Zhao LS.

Hepatobiliary Pancreat Dis Int. 2009 Jun;8(3):273-7.

PMID:
19502167
[PubMed - indexed for MEDLINE]
Free Article
18.

Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.

Wali A, Srinivasan R, Shabnam MS, Majumdar S, Joshi K, Behera D.

Mol Cancer Res. 2006 Feb;4(2):93-9.

PMID:
16513840
[PubMed - indexed for MEDLINE]
Free Article
19.

A novel approach to simultaneously scan genes at fragile sites.

Willem P, Brown J, Schouten J.

BMC Cancer. 2006 Aug 8;6:205.

PMID:
16895604
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Aberrations of the FHIT gene and Fhit protein in canine lymphoma cell lines.

Hiraoka H, Minami K, Kaneko N, Shimokawa Miyama T, Okamura Y, Mizuno T, Okuda M.

J Vet Med Sci. 2009 Jun;71(6):769-77.

PMID:
19578286
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk